Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2020-03-23 Sale | 2020-03-25 5:28 pm | Neon Therapeutics Inc. | NTGN | Access Industries Holdings LLC Clal Biotechnology Industries Ltd. ACCESS INDUSTRIES LLC ACCESS INDUSTRIES MANAGEMENT LLC Blavatnik Len 10% Owner | 252,044 | $2.1933 | $552,802 | 2,836,766 (Indirect Direct) | View |
| 2020-03-19 Sale | 2020-03-23 9:00 pm | Neon Therapeutics Inc. | NTGN | Access Industries Holdings LLC Clal Biotechnology Industries Ltd. ACCESS INDUSTRIES LLC ACCESS INDUSTRIES MANAGEMENT LLC Blavatnik Len 10% Owner | 93,389 | $2.2451 | $209,664 | 3,004,524 (Indirect Direct) | View |
| 2019-11-25 Sale | 2019-11-27 5:01 pm | Neon Therapeutics Inc. | NTGN | GAYNOR RICHARD President of R&D | 65,322 | $1.307 | $85,373 | 156,500 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2020-05-06 Disposition | 2020-05-06 9:09 pm | N/A N/A | Neon Therapeutics Inc. | NTGN | Zausner Meryl Director | 72,500 | $0 | 0 (Direct) | View |
| 2020-05-06 Disposition | 2020-05-06 9:09 pm | N/A N/A | Neon Therapeutics Inc. | NTGN | TEPPER ROBERT I Director 10% Owner | 9,774,136 | $0 | 0 (Direct) | View |
| 2020-05-06 Disposition | 2020-05-06 9:08 pm | N/A N/A | Neon Therapeutics Inc. | NTGN | SHERWIN STEPHEN A Director | 82,500 | $0 | 0 (Direct) | View |
| 2020-05-06 Disposition | 2020-05-06 9:08 pm | N/A N/A | Neon Therapeutics Inc. | NTGN | Pfeffer Cary Director | 32,500 | $0 | 0 (Direct) | View |
| 2020-05-06 Disposition | 2020-05-06 9:07 pm | N/A N/A | Neon Therapeutics Inc. | NTGN | LANDER ERIC S Director | 166,500 | $0 | 0 (Direct) | View |
| 2020-05-06 Disposition | 2020-05-06 9:07 pm | N/A N/A | Neon Therapeutics Inc. | NTGN | Kamen Robert Director | 32,500 | $0 | 0 (Direct) | View |
| 2020-05-06 Disposition | 2020-05-06 9:07 pm | N/A N/A | Neon Therapeutics Inc. | NTGN | Bazemore Robert B Director | 46,500 | $0 | 0 (Direct) | View |
| 2020-05-06 Disposition | 2020-05-06 9:06 pm | N/A N/A | Neon Therapeutics Inc. | NTGN | GAYNOR RICHARD President of R&D | 528,788 | $0 | 0 (Direct) | View |
| 2020-05-06 Disposition | 2020-05-06 9:06 pm | N/A N/A | Neon Therapeutics Inc. | NTGN | Siegel Jolie VP, General Counsel | 321,821 | $0 | 0 (Direct) | View |
| 2020-05-06 Disposition | 2020-05-06 9:06 pm | N/A N/A | Neon Therapeutics Inc. | NTGN | Al-Wakeel Yasir B. Chief Financial Officer | 550,755 | $0 | 0 (Direct) | View |
| 2020-05-06 Disposition | 2020-05-06 9:05 pm | N/A N/A | Neon Therapeutics Inc. | NTGN | O'Dowd Hugh President & CEO | 1,538,779 | $0 | 0 (Direct) | View |
| 2020-02-29 Tax Withholding | 2020-03-02 6:39 pm | N/A N/A | Neon Therapeutics Inc. | NTGN | Siegel Jolie VP, General Counsel | 2,845 | $1.5 | 161,821 (Direct) | View |
| 2020-02-29 Tax Withholding | 2020-03-02 6:39 pm | N/A N/A | Neon Therapeutics Inc. | NTGN | GAYNOR RICHARD President of R&D | 5,625 | $1.5 | 210,410 (Direct) | View |
| 2020-02-29 Tax Withholding | 2020-03-02 6:39 pm | N/A N/A | Neon Therapeutics Inc. | NTGN | Al-Wakeel Yasir B. Chief Financial Officer | 4,891 | $1.5 | 196,965 (Direct) | View |
| 2020-02-29 Tax Withholding | 2020-03-02 6:38 pm | N/A N/A | Neon Therapeutics Inc. | NTGN | O'Dowd Hugh President & CEO | 9,783 | $1.5 | 776,085 (Direct) | View |
| 2020-02-25 Tax Withholding | 2020-02-27 6:21 pm | N/A N/A | Neon Therapeutics Inc. | NTGN | Al-Wakeel Yasir B. Chief Financial Officer | 5,385 | $1.51 | 201,856 (Direct) | View |
| 2020-02-25 Tax Withholding | 2020-02-27 6:21 pm | N/A N/A | Neon Therapeutics Inc. | NTGN | Siegel Jolie VP, General Counsel | 5,334 | $1.51 | 164,666 (Direct) | View |
| 2020-02-25 Tax Withholding | 2020-02-27 6:21 pm | N/A N/A | Neon Therapeutics Inc. | NTGN | GAYNOR RICHARD President of R&D | 5,465 | $1.51 | 216,035 (Direct) | View |
| 2020-01-12 Option Award | 2020-01-13 5:27 pm | N/A N/A | Neon Therapeutics Inc. | NTGN | Siegel Jolie VP, General Counsel | 65,000 | $0 | 170,000 (Direct) | View |
| 2020-01-12 Option Award | 2020-01-13 5:20 pm | N/A N/A | Neon Therapeutics Inc. | NTGN | O'Dowd Hugh President & CEO | 240,000 | $0 | 785,868 (Direct) | View |
| 2020-01-12 Option Award | 2020-01-13 5:01 pm | N/A N/A | Neon Therapeutics Inc. | NTGN | GAYNOR RICHARD President of R&D | 65,000 | $0 | 221,500 (Direct) | View |
| 2020-01-12 Option Award | 2020-01-13 5:00 pm | N/A N/A | Neon Therapeutics Inc. | NTGN | Al-Wakeel Yasir B. Chief Financial Officer | 65,000 | $0 | 207,241 (Direct) | View |
| 2019-11-25 Option Award | 2019-11-25 5:25 pm | N/A N/A | Neon Therapeutics Inc. | NTGN | Siegel Jolie VP, General Counsel | 75,000 | $0 | 105,000 (Direct) | View |
| 2019-11-25 Option Award | 2019-11-25 5:25 pm | N/A N/A | Neon Therapeutics Inc. | NTGN | GAYNOR RICHARD President of R&D | 75,000 | $0 | 221,822 (Direct) | View |
| 2019-11-25 Option Award | 2019-11-25 5:24 pm | N/A N/A | Neon Therapeutics Inc. | NTGN | Al-Wakeel Yasir B. Chief Financial Officer | 75,000 | $0 | 142,241 (Direct) | View |